Pfizer vaccine approved for use in Bangladesh
Published: May 27, 2021 |
Updated: May 27, 2021
Vaccine, developed by US company Pfizer and German biotechnology company Bioentech, has been approved by the Department of Drug Administration for emergency use in Bangladesh.
A press release issued by the department on Thursday, May 27 said that a total of four vaccines for coronavirus have been approved in Bangladesh.
Earlier, the Department of Drug Administration approved the Oxford-AstraZeneca Covishield made at the Serum Institute in India, the Russian made Sputrik-V and the Chinese made Sinofarm.
News Room, May 27,2021